Cost Information

Insurance Coverage and STEGLUJAN™ (ertugliflozin and sitagliptin)

Figuring out what you might pay out of pocket for a prescription medicine can be confusing. What you pay will depend on many factors, including your insurance situation and if there are financial support options available to you. At Merck, we believe that you should be better able to understand what you can expect to pay out of your own pocket for your prescription medicine.

The list price for a 30 day prescription of STEGLUJAN is $549.90.* Most people will not pay the list price, although it may have an impact on your out-of-pocket costs. The amount you pay will depend on many factors, including your insurance situation. The information below will help you better estimate what you may pay for your prescription medicine based on your insurance situation and also cover financial assistance that may be available to you. For the actual out-of-pocket cost of your prescription, talk to your insurance provider, who knows the details of your plan if you have insurance, or contact your health care team's office for help.

*The recommended starting dose of STEGLUJAN is 5 mg ertugliflozin/100 mg sitagliptin, once daily, taken in the morning, with or without food. In patients tolerating STEGLUJAN, the dose may be increased to a maximum recommended dose of 15 mg ertugliflozin/100 mg sitagliptin, once-daily, if additional glycemic control is needed. The list price does not include other treatment-related costs. The list price is current as of March 2020.

The out-of-pocket costs below do not include the other medicines that you may take with STEGLUJAN.

Choose an option below that best describes your insurance situation:

I have commercial insurance through an employer or a private policy that covers STEGLUJAN

For patients with commercial insurance, 89% of patients paid no out-of-pocket costs for a 30-day supply of STEGLUJAN. For those patients who did have out-of-pocket costs, 80% of patients paid between $10 and $580 for a 30-day supply.1

  • What you pay for STEGLUJAN will largely depend on your insurance plan. Each plan has different out-of-pocket costs for the medicines they cover and could include an annual deductible. If you haven't met your deductible, you may pay a higher out-of-pocket cost and could pay an amount close to the list price above, until you meet your deductible.

For eligible, privately insured patients, with the Coupon for STEGLUJAN, you may pay as little as $0 per prescription on each of up to 12 qualifying prescriptions. Maximum savings is $583 per prescription. Not all patients are eligible. Certain restrictions apply. Please see Terms and Conditions. Click here to see the coupon offer.

1 IQVIA™: OPC Provider for the period March 1, 2019 to February 29, 2020 reflecting real-world claims activity for 30-day prescriptions from retail and mail order pharmacies for which data is available in the IQVIA™: OPC Provider database. Reported ranges are based on actual final patient out-of-pocket costs (for commercially insured patients, after application of any e-voucher, co-pay card, or coupon) for patients prescribed STEGLUJAN. Reported ranges include both paid and reversed claims for 30-day prescriptions for which data is available. All out-of-pocket cost values are based on a 30-day supply. Data accessed as of March 2020. All rights reserved.

Please note that a patient's cost may differ from the amounts depicted above.

I have coverage for STEGLUJAN through Medicare

For patients with Medicare Part D coverage, 80% of patients paid between $0 and $260 for a 30-day supply of STEGLUJAN.1

  • What you pay for STEGLUJAN will largely depend on your insurance plan. Each Medicare prescription drug benefit plan has a different out-of-pocket cost for the medicines it covers, and could include an annual deductible. If you haven't met your deductible, you may pay a higher out-of-pocket cost and could pay an amount closer to the list price above until you meet your deductible. If you need assistance to understand your Medicare prescription drug coverage and out-of-pocket costs, contact your Medicare Plan Sponsor. If you need access to Medicare Part D coverage, visit https://www.medicare.gov/drug-coverage-part-d.

1 IQVIA™: OPC Provider for the period March 1, 2019 to February 29, 2020 reflecting real-world claims activity for 30-day prescriptions from retail and mail order pharmacies for which data is available in the IQVIA™: OPC Provider database. Reported ranges are based on actual final patient out-of-pocket costs for patients prescribed STEGLUJAN. Reported ranges include both paid and reversed claims for 30-day prescriptions for which data is available. For Medicare, low income subsidy patients are excluded from out-of-pocket cost calculations. All out-of-pocket cost values are based on a 30-day supply. Data accessed as of March 2020. All rights reserved.

Please note that a patient's cost may differ from the amounts depicted above.

I have coverage for STEGLUJAN through Medicaid

For most people on Medicaid, patient out-of-pocket costs for prescription medicines like STEGLUJAN range from $4 to $8 per prescription. Your out-of-pocket costs may vary if you have a higher income. To learn more about Medicaid in your state and find out if you're eligible, visit https://www.medicaid.gov/medicaid-and-you/index.html.1

1 Centers for Medicare & Medicaid Services (CMS). Cost sharing out of pocket costs. https://www.medicaid.gov/medicaid/cost-sharing/out-of-pocket-costs/index.html. Accessed March 2020.

I don’t have insurance or STEGLUJAN is not covered by my insurance plan

If you don’t have insurance coverage, or your insurance does not cover your treatment with STEGLUJAN, you could pay an amount closer to the list price shown above, plus any additional charges depending on where you receive your medicine.

I’m the type to not make excuses.

I’m the type to not make excuses.

Learn About STEGLUJAN™ (ertugliflozin and sitagliptin)

STEGLUJAN is built to build on your efforts.

STEGLUJAN is built to build on your efforts.


Important Safety Information

Do not take STEGLUJAN™ (ertugliflozin and sitagliptin) if you have severe kidney problems or are on dialysis. Do not take STEGLUJAN if you are allergic to sitagliptin (JANUVIA®), ertugliflozin (STEGLATRO™), or any of the ingredients in STEGLUJAN. Symptoms of a serious allergic reaction to STEGLUJAN may include skin rash, raised red patches on the skin (hives), swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing.

STEGLUJAN may cause serious side effects including:

  • Pancreatitis (inflammation of the pancreas), which may be severe and lead to death. Before taking STEGLUJAN, tell your doctor if you have ever had pancreatitis. Stop taking STEGLUJAN and call your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.
  • Dehydration (loss of body water and salt), which may cause you to feel dizzy, faint, lightheaded, or weak, especially when you stand up (orthostatic hypotension). You may be at higher risk of dehydration if you have low blood pressure; take medicines to lower your blood pressure, including water pills (diuretics); have kidney problems; are on a low-salt diet; or are 65 years of age or older.
  • Vaginal yeast infection. Talk to your doctor if you have vaginal odor, white or yellowish vaginal discharge (discharge may be lumpy or look like cottage cheese), or vaginal itching.
  • Yeast infection of the penis (balanitis or balanoposthitis). Talk to your doctor if you have redness, itching, or swelling of the penis; rash of the penis; foul-smelling discharge from the penis; or pain in the skin around your penis. Men who are not circumcised may have swelling of the penis that makes it difficult to pull back the skin around the tip of your penis.
  • Heart Failure. Tell your doctor if you have ever had heart failure or have problems with your kidneys. Contact your doctor right away if you have symptoms of heart failure: increasing shortness of breath or trouble breathing (especially when you lie down); swelling or fluid retention (especially in the feet, ankles, or legs); an unusually fast increase in weight; or unusual tiredness.
  • Ketoacidosis (increased ketones in the blood or urine) has happened in people with type 1 and type 2 diabetes during treatment and also in people with diabetes who were sick or who had surgery during treatment with STEGLUJAN. Ketoacidosis is a serious condition, which may require hospitalization and may lead to death. Symptoms may include nausea, tiredness, vomiting, trouble breathing, and abdominal (stomach area) pain. If you get any of these symptoms, stop taking STEGLUJAN and call your doctor. If possible, check for ketones in your urine or blood, even if your blood sugar is less than 250 mg/dL.
  • Kidney problems. Talk to your doctor right away if you reduce the amount you eat or drink (for example, if you are sick or cannot eat), or if you lose liquids from vomiting, diarrhea, or excessive heat exposure.
  • Serious urinary tract infections (UTI), some that lead to hospitalization. Tell your doctor if you have any symptoms of a UTI, including a burning feeling when passing urine, a need to urinate often, an urgent need to urinate, pain in the lower part of your stomach (pelvis), or blood in the urine with or without fever, back pain, nausea, or vomiting.
  • Amputations. STEGLUJAN may increase your risk of lower limb amputations. Call your doctor right away if you have new pain or tenderness, any sores, ulcers, or infections in your leg or foot. Your doctor may decide to stop your STEGLUJAN if you have any of these signs or symptoms. Talk to your doctor about proper foot care. You may be at a higher risk of lower limb amputation if you have or have had: a history of amputation; blocked or narrowed blood vessels; damage to the nerves (neuropathy) in your leg; and/or diabetic foot ulcers or sores.
  • Low blood sugar (hypoglycemia) can occur if you take STEGLUJAN with another medicine that can cause low blood sugar, such as sulfonylureas or insulin. Symptoms include headache, drowsiness, hunger, irritability, dizziness, confusion, sweating, feeling jittery or shaky, weakness, and/or fast heartbeat. Follow your doctor’s instructions for treating low blood sugar.
  • Necrotizing fasciitis, a rare but serious bacterial infection of the tissue under the skin in the area between and around the anus and genitals (perineum), has happened in women and men who take medicines that lower blood sugar in the same way as STEGLUJAN, which may lead to hospitalization, multiple surgeries, and death. Seek immediate medical attention if you have fever or feel very weak, tired, or uncomfortable and you develop: pain or tenderness, swelling, or redness of skin in the perineum.
  • Increased fats in your blood (bad cholesterol or LDL).
  • Serious allergic reactions. If you have any symptoms of a serious allergic reaction, stop taking STEGLUJAN and call your doctor right away.
  • Joint pain. Some people who take medicines called DPP-4 inhibitors, one of the medicines in STEGLUJAN, may develop severe joint pain. Call your doctor if you have severe joint pain.
  • Skin reaction. Some people who take medicines called DPP-4 inhibitors, one of the medicines in STEGLUJAN, may develop a skin reaction called bullous pemphigoid that can require hospitalization. Tell your doctor if you develop blisters or the breakdown of the outer layer of your skin. Your doctor may tell you to stop taking STEGLUJAN.

The most common side effects of ertugliflozin include genital yeast infections and changes in urination.

The most common side effects of sitagliptin include upper respiratory tract infection, stuffy or runny nose and sore throat, headache, and stomach upset and diarrhea.

What is STEGLUJAN?

STEGLUJAN is a prescription medicine that contains sitagliptin (JANUVIA®) and ertugliflozin (STEGLATRO™). STEGLUJAN is used with diet and exercise to help lower blood sugar levels in adults with type 2 diabetes.

STEGLUJAN is not for type 1 diabetes and/or diabetic ketoacidosis (increased ketones in the blood or urine). If you have had pancreatitis (inflammation of the pancreas), it is not known if you have a higher chance of getting it while taking STEGLUJAN.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please read the accompanying Medication Guide for STEGLUJAN and discuss it with your health care team. The physician Prescribing Information also is available.